Drug Development

Listings
  • Minipig Cardiomyocytes

    Minipig Cardiomyocytes

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Minipig cardiomyocytes from Creative Bioarray are isolated from the minipig heart tisse. The method we use to isolate minipig cardiomyocytes was developed based on a combination of established and our proprietary methods. The minipig cardiomyocytes a...

  • Beta-TC-6

    Beta-TC-6

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C9159W Description The cell line was derived from a pancreatic tumor (insulinoma) arising in a transgenic mouse. Species Mus musculus (Mouse) Source Pancreas https://www.creative-bioarray.com/Beta-TC-6-CSC-C9159W-item-42092.htm

  • ATDC5

    ATDC5

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6480J Description Differentiate to chondrocytes, unidentifiable pigment cells. Teratocarcinoma AT805 derived. Species Mus musculus (Mouse) https://www.creative-bioarray.com/atdc5-item-csc-c6480j-43080.htm

  • ECPC-3

    ECPC-3

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6391J Description Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene. Species Mus musculus (Mouse) Source Brain https://www.creative-bioarray.com/ecpc-3-item-csc-c6391j-42991.htm

  • ECPC-4

    ECPC-4

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6392J Description Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene. Species Mus musculus (Mouse) Source Brain https://www.creative-bioarray.com/ecpc-4-item-csc-c6392j-42992.htm

  • LM8

    LM8

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6376J Description A highly metastatic cell line derived from Dunn's osteosarcoma (C3H mouse origin). Species Mus musculus (Mouse) Source Bone https://www.creative-bioarray.com/lm8-item-csc-c6376j-42976.htm

  • MB-03

    MB-03

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Established from the larvae of the butterfly Mamestra brassicae (family Noctuidae, subfamily Noctuinae) (cabbage moth; Kohleule) https://www.creative-bioarray.com/MB-03-CSC-C6203X-item-1683.htm

  • MBT-2

    MBT-2

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6483J Description Murine transitional cell carcinoma induced by FANFT. Species Mus musculus (Mouse) Source Bladder Metastasis https://www.creative-bioarray.com/mbt-2-item-csc-c6483j-43083.htm

  • Immortalized Mouse Microglia (BV2)

    Immortalized Mouse Microglia (BV2)

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Immortalized Mouse Microglial (BV2) cells have become a popular substitute for primary microglia in many experiments. These cells were derived from C57/BL6 neonatal microglia and immortalized using the v-raf/v-myc-carrying J2 retrovirus. BV2 cells ex...

  • GL261

    GL261

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Established as in vitro growing cell culture in the mid 1990s from the Gl261 tumor which was induced in 1939 by intracranial injection of 3-methylcholanthrene into C57BL/6 mice and subsequently maintained by serial transplantation in syngeneic mouse ...

  • B9

    B9

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cells are a subclone derived from B13.29 (first described as clone 9.9) by fusion of BALB/c spleen cells with SP2/0-AG14 myeloma cells; this hybridoma is a non-producer. B9 is a mouse B cell hybridoma line that requires Interleukin 6 (IL-6) for survi...

  • SPC-BM-36

    SPC-BM-36

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Derived from larvae of a silkworm (species Bombyx mori, family Bombycidae, order Lepidoptera) (Seidenspinner) https://www.creative-bioarray.com/SPC-BM-36-CSC-C6198X-item-1678.htm